Allen & Overy advises the lending banks syndicate on a EUR451 million financing in connection with the EUROAPI’s contemplated listing on Euronext Paris
For media enquiries relating to this topic, please contact:
Headlines in this article
Related news and insights
News: 09 February 2024
News: 29 January 2024
News: 25 January 2024
Allen & Overy has advised the banking syndicate, composed of BNP Paribas, Bank of America, Crédit Agricole Corporate and Investment Bank, Deutsche Bank, J.P. Morgan, Natixis and Société Générale, on a revolving credit facility provided to EUROAPI in connection with its contemplated listing on Euronext Paris.
EUROAPI’s listing on Euronext Paris aims to reinforce its status as partner of choice for all pharmaceutical laboratories and biotech companies and clarify EUROAPI’s independence from Sanofi. EUROAPI first day of trading on Euronext Paris is expected to occur on May 6.
This EUR451 million five-year revolving credit facility will help EUROAPI, a leading player in active pharmaceutical ingredients, to finance its general needs and potential future acquisitions.
The Allen & Overy team in Paris was composed of Julien Roux (Partner), Tristan Jambu-Merlin (Senior Associate) and Quitterie d'Andoque (Associate), and also included Mathieu Vignon (Partner) and Virginie Chatté (Senior Associate) on tax aspects.